Harbour is eligible for payments of $90m, with potential development and commercial milestones of up to $1.035bn.

Bristol Myers Squibb said in its fourth-quarter results update this morning that it will double down on an ongoing cost-cutting programme announced last year. The company still intends to slash $1.5 ...

Bristol Myers Squibb (BMS) has agreed to co-develop and co-commercialize BioNTech’s cancer-fighting bispecific antibody candidate BNT327 across numerous solid tumor types through a collaboration that ...

A battery management system (BMS) monitors and controls batteries in vehicles such as more-electric aircraft and electric cars. It needs to undergo rigorous tests under nominal and extreme conditions ...

Automotive BMS must undergo rigorous testing to verify that it meets stringent performance and safety standards. BMS emulation involves using hardware and software tools to simulate the behavior of a ...

As a top cancer executive at Bristol Myers Squibb, Kristen Hege oversaw development of the cell therapy that would become Abecma, the first FDA- approved treatment for multiple myeloma that’s made ...

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

If you have worked with or looked at battery systems, you have most likely heard of a battery management system or BMS. Since Nuvation Energy provides off-the-shelf battery management systems for ...